Increased yield from novel nano-electrospray workflows in LC-MS based proteomics
- Date: Sep 18, 2012 - 15:00 - 16:00 (local time)
- Presenter: Enter an Author name
- Categories: Proteomics & Genomics / Proteomics / Base Peak
Latest webinar from Thermo Scientific
Increased yield from novel nano-electrospray workflows
in LC-MS based proteomics
Tuesday, September 18, 2012 – 15:00 UTC
08:00 PT | 11:00 ET | 16:00 UK | 17:00 CET
Click here to check the time in your own country >>>
Nano-electrospray is widely used in proteomics for its high sensitivity but it’s also acknowledged it requires a lot of experience and constant attention to detail in order to provide and assure consistent performance and high quality results.
Learn how scientists from The Hospital for Sick Children and University of Toronto have used EASY-Spray technology to improve their experimental results while simultaneously simplifying daily procedures.
The webinar will cover initial productivity gains as well as optimized workflows in the areas of discovery and quantitation on complex samples from lung cancer cell lines and a comparison study of glyco-peptide capture and detection.
Who Should Attend:
- Proteomics scientists
- Molecular biologists
- Core lab managers
Advanced Protein Technology Centre
Hospital for Sick Children
Paul Taylor: Biography
Paul Taylor did his undergraduate studies in the Faculty of Medicine at Memorial University of Newfoundland and graduate studies in the Department of Microbiology and Infectious Diseases at the University of Calgary. He worked at MDS Proteomics as a research associate, scientist and became the Director of Operations for the Analytical Division. He joined the laboratory of Michael Moran at The Hospital for Sick Children in Toronto in 2007 where he remains. He is also the manager for the Advanced Protein Technology Centre at the hospital.
Dept of Medical Biophysics
University of Toronto
Thomas Kislinger: Biography
Thomas Kislinger is a Scientist at the Ontario Cancer Institute, and the Associate Professor at the Department of Medical Biophysics. He is a Canadian Research Chair in Proteomics and Cancer Research at the University of Toronto. The main interest of the Kislinger lab is the application of proteomics and bioinformatics with a focus on translation proteomics (cancer and cardiac biology). We are using both discovery and targeted proteomics approaches to address these questions. An additional interest of our lab is the systematic analyses of cell surface proteomes using direct labeling approaches.